Dr Nik Zeps
St John of God HealthCare, Perth, Australia
Dr Zeps is Director of Research at St John of God Subiaco, Murdoch and Midland Hospitals.

He was a member of the Australian Health Ethics Committee from 2006-2012 and the Research Committee of the National Health and Medical Research Council (NHMRC) from 2009-2015. He is a board member of the Australian Clinical Trials Alliance and co-chair of the international Cancer Genome Consortium communication committee. 

His objective as Director of Research is to integrate clinical research and teaching into routine healthcare delivery to improve the lives of patients and their families. 



Integrating Research into Routine Clinical Care

In 2012 the Australian Government published a review of Health and Medical Research in Australia that became known as the ‘Mckeon review’, after the chair of the working group. A central theme of this review was that research should be integrated into healthcare delivery itself wherever possible to ensure that the fruits of the research were readily translated into alleviating the burden of disease. For many involved in healthcare delivery the need for such integration is obvious; however, there has been a gradual separation of research from service delivery over the past two decades and many health services now regard research as an additional cost or burden rather than as core business.

The creation of Research Governance Frameworks has emphasized this, which whilst they deliver important accountability for expenditure actually serves to impede rather than facilitate research. In this presentation I will outline how a large private not-for-profit hospital network has taken up the proposals in the Mckeon review and reversed the trend of reduced clinical research activity that is prevalent elsewhere. In addition, this presentation will outline with examples how integrating research can be done as part of an overall framework aimed at solving the issues of variation in healthcare outcomes that are seen across the sector. The concept of randomized embedded multicenter adaptive platforms (REMAP) and the solutions to the regulatory and structural difficulties associated with these will be presented.